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rabbit alveolar mecronhngrs and human svnovial 
fibroblasts in response to infiamniatory mediato& such 
as interleukin-1 and tumour necrosis factor-& (reviewed 
in IS]). Stramclysin has been shown to cleave n,AT [6), 
although no detailed studies were undertaken. In par- 
ticular, it is not known whether the cleavage of nlAT 
is accompanied by inactivation and the position of the 
peptide bond hydrolysis has not been ascertained. Here 
we report that recombinant human stromelysin has the 
capacity to inactivate human plasma (r,AT by cleaving 
the p0lypeptid.e chain near to the reactive site at the 
Pro’57-Met358 peptide bond. 
1. INTRODUCTION 
Wumnn plasma CYI ancirrypsin &AT) inhibits the 
tissue-degrading activity of clasrasc, a serine pro&case 
released by infiltrating ncutrophils at sites of inflamma- 
tion, by forming a stable 1: 1 complex (rcvicwcd in [I]). 
It has been suggcsred that in certain inflammatory con- 
ditions, sue h as pulmonary emphysema and 
rheumatoid arthritis, tissue destruction is caused by an 
crlhT-elastase imbalance, since inflammatory fluids 
taken from patients with these diseases contain a 
significant proportion of cv,AT which is inactive as an 
inhibitor (reviewed in [2]). 
This inactivation has been attributed to the oxidation 
of a critical reactive centre methionine residue (at posi- 
tion 358), mediated by the neutrophil myeloperoxidase- 
Cl-/Hz02 system [23. Recently, however, it has been 
shown that human neutrophil collagenase, a 
metalloproteinase, is capable of inactivating human 
(uIAT by catalytic leavage at the Phe352-Leu353 peptide 
bond [3,4]. It was therefore suggested that collagenase 
may contribute to the persisting activity of ncutrophil 
elastase. 
Human stromelysin isa connective tissue metallopro- 
teinase released by cells such as human lung fibroblasts, 
2. MATERIALS AND METHODS 
2. I. Activoriotr OJ INIC~I s~romlysitr arld essay of acriviry 
Human recombinant prostromclysin was prepared as &scribed 
earlier 17’1. WC are grateful to Dr A. Docherty and collcagucs at 
Celltcch (Slough, UK) for expression of the recombinant protein. 
Prostromelysin was activated by incubating with 4- 
aminophenylmercuric acetate (APMA; 1-2 mM) foe 2-4 h at 37°C. 
Conversion of prostromelysin to stromelysin was confirmed by 10% 
SDS-PAGE with silver staining and activity assays [7]. Although 
trypsin is a more efficient activator of prostromelysin than APMR 
171, trypsin was found to interfere in the assay of elastase inhibitory 
capacity, 
Activated stromclysin was assayed using [‘klacetylated fl-cascin at 
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37°C For 1 h or 4 h (71, One unit of mmmclysin drtgadcs 1 pg of #- 
cascin per niin at 37°C. 
2.2. Incubarion of CYIAT with strome/ysin 
Human plasma alAT (Novabiochem, Nottingham, UK) was in- 
cubated at 37°C with APMA-activated stromelysin in IOU mM Tris- 
AbbreviuUotts: alAT, cul-antitrypsin; APMA, 4-aminophenylmer- HCI, containing 30 mM CaCl2, pH ‘?,6. The concentration of 
curie acetate stromelysin and the incubation times were varied as indicated. 
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3. RESULTS AND DISCUSSION 
The sttoPnclysin-cl?talysed hydrolysis of il sin& pep- 
tide bond within the polypeptide chain of CYIAT was 
demonstrated by gel electrophoresis, reversed-phase 
HPLC and N-terminal sequencing. A parallel inactiva- 
When the rrlAT‘-degrading activity of the above 
atromclyain prcparntioti wns tcstdd 81 a rceombinrlnt 
protein/rrlAT ratio of 1: 10 (w/w), less than 50% of fhe 
0,AT was cleaved after 4 h (Fig. I%)). This activity is 
lower than that of rabbit-synoviul stramelysin: at m 
tXi!.ytW/~r~AT ratio Of I:200 (W/W), iippPOXi~Ii~tCly 
500-o ctcavagc of rulAT wns obtained nftcr 4 h (61. It is 
known [7) that the cnscin-&grading Octivity of human 
stramclysin (both natural and recombinant) is about 
ten times lower than thar of the rabbit enzyme, The 
rmsons for this 8rc unclear, but activation of purified 
human prostrotnclysin with APMA does not appear to 
yivc complrtc conversion to the active form [7]. In the 
study by Chin et al. [6] mentioned above, a crude 
isolate of srromelysin from rabbit synovial fibroblasts 
w;s$ activated with APMA to allow the isolation of all 
active enzymes in the final purification s:eps. Furthcr- 
more, when WC activated a second batch of pro- 
stromclysin in an identical iashion to the first, a higher 
activity was obtained: almost all of the CYIAT was cleav- 
ed in 4 h at a 1: 10 (w/w) ratio (Fig. IB). For COW 
Fig. 1. Cleavage of atAT by stromelysin. (A) Time course. cv,AT (28.8 bdg) was mixed with APMW-activated stromelysin (17.20 units; specific 
activity 665 units/mg) and incubated at 37%. A control sample contained alAT alone. Aliquots were removed after various time intervals, added 
to SDS sample buffer and boiled for 5 min. Samples were then analysed by IO-20% gradient SDS,,PACiE followed by immunoblotting with an 
anti-human alAT antibody (see section 2.3). (Lane I) cu,AT incubated alone, (Lanes 2-6) (Y,AT incubated with stromelysin for: (2) 15 min; (3) 
30 min; (4) 90 min; (5) 180 min; (6) 360 min. (Lane 7) alAT incubated with an equirnolar concentradon of human neutrophil elastase 
(Novabiochem) for S min at 37OC. (B) Comparison of two stromelysin batches. (Lane 1) cr,AT incubated with an equimoiar concentration oi 
human neutrophil elastase for 5 min at 37°C; (lane 2) a,AT alone incubated for 4 h at 37°C; (lanes 3 and 4) alAT incubated with two different 
batches of APMA-activated stromelysin at a recombinant protein/alAT ratio of l:!O (w/w) for 4 h at 37°C: (lane 3) batch 1 stromelysin (665 
units/mg); (lane 4) batch 2 stromelysin (856 units/mg). Numbers to the side of each panel indicate the positions of molecular mass marker pro- 
teins, whilst letters indicate: C, ru!AT-elastase complex (83 kDe); N, native N,AT (54 kDa); P, high-Mr cleavage fragment of cr,AT (50 kDa). 
When rhc low-hlr frnylmrnt, iaoliltcd by rcvcrxctt- 
phase HBtC (Fig, 3) wax xubjjrctcd to xix cyclcx sf NW 
terminal scqrrcncing, the seqwcnes obtained was Mct- 
Ser-lid-Fro-ProGlu. ‘fhia indicates that cleavaye 043 
currcd at the Pra”‘-MctZf” (Px-PI) pcptidc bunel, one 
peptide bond to the N-terminal side uf the reactive ccR- 
UC, The rcnetivc rrntrr of crrAT is r;ituarcd within BR 
exposed loop region (r&dues 34&-363, which id 
known to be protcaae-scnritive [l].
The Pro “I-Met”’ clcavnpc site in EWIAT ix also 
sharccl by i=mrtletmrta~ aerrrgt’ttcm clustasc [ 101 and 
mouse macrophaac elastasc [I I]. Furthcrmorc, whilst 
the printary site BFLTIAT cleavngc by human Rcutrophil 
collagenase is F%P-LeP (F+Pb), a secondary 
clcavagc at Pro’“7-Met”n occurs after prolonged in- 
cubation [3]. MOW? macrophagc clastasc is regarded as 
the inflnmc-natory cell counterpart to stromclysin, 
because the two enzymes have similar substrate 
specificities [S, 1 I]. It has already brcn suggested that 
macrophage clastasc may contribute co tissue dcstruc- 
tion in inflatrmatory conditions uch as emphysema by 
2 3 4 5 6 7 a 
Time (h) 
Fig. 2. Time course of inactivation of cv]AT by various amounts of 
added stromelysin. arAT (28.8 /rg) was mixed with the following 
amounts of Ai%A-activated stromeiysiti (665 ii&./ii&: 0.33 (A), 
1.72 (8), 3.44 (e), 8.60 (0) and 17.20 units (A). A control sample 
(0) contained alAT alone. The reaction mixtures were incubated at 
37”C, aliyuots were removed after various time intervals and the 
elastase inhibitory capacity was measured as described in section 2.4. 
proteolyticnlly inactivating ru\AT [l I], In the light of 
our present findings, WC suggest that stromclycin may 
play a similar pathologic role. Consistent with such a 
ralc for stromelysin, is the recent observation that this 
enzyme is present at high concentrations inrheumatoid 
synovinl fluids, being approximately 20.fold more con- 
ccntrated rhan collagenase (WI. Lark, Merck Sharp & 
Dahme, Rahway, NJ, manuscript submitted). Within 
the rheumatoid joint, the negatively charged cartilage 
surface interferes with the ability of alAT to inhibit 
elastase, since cvlAT carries a Ret negative charge at 
neutral pH [12]. Thus, the proteolytic inactivation of 
cqAT by stromclysin-releasing cells present within the 
cartilage or immediately adjacent o the cartilage, may 
be particularly significant. 
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